Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia

Journal of Perinatal Medicine

Volumn 36, Issue 4, 2008, Pages 359-364

  Kewitz, Gabriele ^a,b   Wudel, Stefan ^a   Hopp, Hartmut ^a   Hopfenmüller, Werner ^a   Vogel, Martin ^a   Roots, Ivar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Public Health Department Steglitz Zehlendorf   (Germany)

Author keywords

Appropriate for gestational age; Broncho pulmonary dysplasia; Chorioamnionitis; Dexamethasone; Extremly low birth weight infants; Intrauterine growth; Intrauterine infection; Placenta histology; Preterm infants

Indexed keywords

DEXAMETHASONE; FUROSEMIDE; SPIRONOLACTONE;

ARTICLE; BIPARIETAL DISTANCE; BIRTH WEIGHT; CHORIOAMNIONITIS; CONTROLLED STUDY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GENDER; GESTATIONAL AGE; HISTOLOGY; HUMAN; INTRAUTERINE INFECTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PLACENTA; PREMATURITY; PRENATAL GROWTH; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; RISK FACTOR; SINGLE DRUG DOSE;

BIRTH WEIGHT; BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; COHORT STUDIES; DEXAMETHASONE; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PREGNANCY; REGRESSION ANALYSIS; RISK FACTORS;

EID: 46749113419     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2008.056     Document Type: Article

References (25)

1. Antonucci R, Contu P, Porcella A, Atzeni C, Chiappe S. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia? J Perinat Med. 2004;32:272-7.
2. Bhandari V, Gruen J. The genetics of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:185-91.
3. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;164:1971-80.
4. Büscher U, Chen FC, Pitzen A, Menon R, Vogel M, Obladen M, et al. II-1 beta, II-6 and G-CSF in the diagnosis of early-onset neonatal infections. J Perinat Med. 2000;28:383-8.
5. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics. 1991;88:421-7.
6. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med. 2002;8:702-10.
7. Davis PG, Thorpe K, Roberts R, Schmidt B, Doyle LW, Kirpalani H. Evaluating "old" definition for the "new" bronchopulmonary dysplasia. J Pediatr. 2002;140:555-60.
8. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342:1500-7.
9. Hübler A, Schlenvoigt D, Dost A, Schramm D, Scheidt B, Kauf E. Association of the IGF/IGFBP axis and respiratory diseases in neonatal patients during the first 6 months of life. Growth Hormone and IGF Research. 2006;16:185-92.
10. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res.1999;46:641-3.
11. Kent A, Dahlstrom J. Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia. J Paediatr Child Health. 2004;40:356-9.
12. Kewitz G, Wudel S, Hopfenmüller W, Vogel M, Hopp H, Roots I, et al. Diagnose des Amnioninfektionssyndroms (AIS) -Histologische Plazentabefunde und Laborparameter bei Mutter und Kind. 2003, ZGN, 207: S1.
13. Lal MK, Manktelow BN, Draper ES, Field DJ. Chronic lung disease of prematurity and intrauterine growth restriction: a population-based study. Pediatrics. 2003;111:483-7.
14. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol. 2002;282:L811-23.
15. Ogunyemi D, Murillo M, Jackson U, Hunter N, Alperson B. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003;13:102-9.
16. Regev RH, Lusky A, Dolfin T, Litmanovitz I, Arnon S, Reichman B. Israel neonatal network. Excess mortality and morbidity among small-for-gestational- premature infants: a population-based study. J Pediatr. 2003;143:186-91.
17. Shaw NJ, Gill AB, Weindling AMW, Cooke RWI. The changing incidence of chronic lung disease. Health Trends. 1993;25:50-3.
18. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82:527-32.
19. Tsao PN, Wei SC, Su YN, Lee CN, Chou HC, Hsieh WS, et al. Placenta growth factor elevation in the cord blood of premature neonates predicts poor pulmonary outcome. Pediatrics. 2004;113:1348-1.
20. nd ed. Berlin, Heidelberg, New York: Springer; 1996.
21. Voigt M, Schneider KTM, Jährig K. Analyse des Geburtsgutes des Jahrganges 1992 der Bundesrepublik Deutschland. Teil 1: neue Perzentilwerte für die Körpermaße von Neugeborenen. Geburtsh.u. Frauenheilk. 1996;56:550-8.
22. Walsh MC, Yao Q, Horbar JD, Carpenter JH, Lee SK, Ohlsso A. Changes in the use of postnatal steroids for bronchopulmonary dyplasia in 3 large neonatal networks. Pediatrics. 2006;118:e1328-35.
23. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996;97:210-5.
24. Watterberg KL, Scott SM, Naeye RL. Chorioamnionitis, cortisol, and acute lung disease in very low birth weight infants. Pediatrics. 1997;99:e6.
25. Zöfel P. Statistik verstehen [To understand statistics]. Scientific compating. An Imprint of Pearson Education. Addison-Wesley; 2002.